Monogram Orthopaedics, Inc. (MGRM)

NASDAQ: MGRM · IEX Real-Time Price · USD
2.060
-0.020 (-0.96%)
At close: Jun 14, 2024, 3:59 PM
2.150
+0.090 (4.37%)
After-hours: Jun 14, 2024, 5:45 PM EDT
-0.96%
Market Cap 65.24M
Revenue (ttm) 364,999
Net Income (ttm) -13.39M
Shares Out 31.67M
EPS (ttm) -0.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 81,834
Open 2.050
Previous Close 2.080
Day's Range 2.000 - 2.190
52-Week Range 1.530 - 6.550
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date May 14, 2024

About MGRM

Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monog... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2016
Employees 28
Stock Exchange NASDAQ
Ticker Symbol MGRM
Full Company Profile

Financial Performance

Financial Statements

News

Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024

Management to Showcase Product Demonstration of mBôs Precision Robotic Surgical System and mVision Technologies AUSTIN, TX / ACCESSWIRE / June 3, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Mono...

11 days ago - Accesswire

Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies

New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position AUSTIN, TX / ACCESSWIRE / May 15, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "C...

4 weeks ago - Accesswire

Monogram Orthopaedics Reports First Quarter 2024 Financial Results

Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024 Engaged Contract Research Organization to Oversee mBôs Ro...

4 weeks ago - Accesswire

Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.

CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities AUSTIN, TX / ACCESSWIRE / May 13, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Mon...

4 weeks ago - Accesswire

Monogram Provides Regulatory Update Following Meeting with FDA

510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven roboti...

6 weeks ago - Accesswire

Monogram Accepted to NVIDIA Inception Program

Collaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs System AUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM)...

2 months ago - Accesswire

Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time

AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical ...

3 months ago - Accesswire

Monogram Orthopaedics Reports Full Year 2023 Financial Results

510(k) Submission with FDA On Track for Second Half of 2024 Shipped mBôs Surgical Robot System to First International Customer Introduced mVision Technologies, a Novel Approach to Registration and Tra...

3 months ago - Accesswire

Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting

Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeons AUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Compa...

4 months ago - Accesswire

Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024

AUSTIN, TX / ACCESSWIRE / January 24, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgica...

5 months ago - Accesswire

Monogram Orthopaedics to Reschedule Robotic Product Demo Live Stream

AUSTIN, TX / ACCESSWIRE / December 14, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgic...

6 months ago - Accesswire

Monogram Orthopaedics to Host Robotic Product Demo Live Stream on Thursday, December 14, 2023 at 11:00 a.m. Eastern Time

- Demo will feature Monogram's mBôs commercial robot with teaser - AUSTIN, TX / ACCESSWIRE / November 30, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical techn...

7 months ago - Accesswire

Monogram Orthopaedics Delivers First Surgical Robot

- First Sale to Major Global Distributor Represents Key Revenue Milestone and Paves the Way for Broader Commercialization - AUSTIN, TX / ACCESSWIRE / November 28, 2023 / Monogram Orthopaedics Inc. (NA...

7 months ago - Accesswire

Monogram Orthopaedics Files Updated Presentation on Form 8-K

- Presentation Highlights MGRM's Competitive Differentiation and Multi-Stage Growth Strategy - AUSTIN, TX / ACCESSWIRE / October 20, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the ...

8 months ago - Accesswire

Monogram Orthopaedics' Next Generation Surgical Robotic System Enters Verification Phase

Completion of the Development Phase Represents a Key Milestone Toward Product Commercialization AUSTIN, TX / ACCESSWIRE / August 14, 2023 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the ...

10 months ago - Accesswire

Monogram Orthopaedics Secures First Conditional Purchase Order to Initiate Pilot Program with Global Distributor

Moves from R&D to Commercialization AUSTIN, TX / ACCESSWIRE / July 18, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstru...

11 months ago - Accesswire

Monogram Orthopaedics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program

AUSTIN, TX / ACCESSWIRE / May 23, 2023 / Monogram Orthopaedics Inc., (NASDAQ:MGRM) ("Monogram" or the "Company") a medical technology company focused on reconstructive joint procedures and orthopedic ...

1 year ago - Accesswire

Monogram Orthopaedics shares rally, Farfetch stock gains and other stocks on the move

Monogram Orthopaedics Inc. MGRM, +62.07% shares surged 278% in premarket trading. The medical technology group began trading on the Nasdaq on Thursday, with the stock ending the first day of trading a...

1 year ago - Market Watch

Monogram Orthopaedics Shares Begin Trading Publicly on NASDAQ

Medical Technology Company Ushering in the Future of Joint Reconstruction Will Trade Under Ticker Symbol "MGRM" AUSTIN, TX / ACCESSWIRE / May 18, 2023 / Monogram Orthopedics (NASDAQ:MGRM), a leader in...

1 year ago - Accesswire

Monogram Orthopaedics Announces Closing of Public Offering of $17,216,147

Shares to Begin Trading on NASDAQ on May 18, 2023 Under the Ticker Symbol "MGRM" AUSTIN, TX / ACCESSWIRE / May 17, 2023 / Monogram Orthopaedics Inc., a leader in developing patient-optimized, 3D-print...

1 year ago - Accesswire